Funding, News and Announcements

This competitive grant program seeks to support quality improvement projects focused on improving the identification and management of ATTR-CM patients.

Projects that will be considered for Pfizer support will focus on improving the identification and management of ATTR-CM patients by providing leadership, best practices, novel clinical pathways, support and/or training of HCPs within a multidisciplinary team environment to improve the quality of care for patients with ATTR-CM.  

Particular consideration will be given to projects intended to improving care, and / or access to care for underrepresented populations (women, individuals of African-American Descent, First Nations, Métis and Inuit or other underrepresented communities)

Read more about this call here.

Deadlines

Internal: March 31, 2023 at 4:30pm. Contact email is ird@dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.

Funder: April 17, 2023. Contact email is amanda.j.stein@pfizer.com.